US Patent 7592331 Macrocyclic factor VIIa inhibitors useful as anticoagulants
Patent 7592331 was granted and assigned to Bristol-Myers Squibb on September, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 16 Sep, 2023
Golden AI
Edits made to:
Article (+91 characters)
Article
Patent abstract
The present invention relates generally to novel macrocycles of Formula (I):
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07592331 Macrocyclic factor VIIa inhibitors useful as anticoagulants US Patent 7592331 Macrocyclic factor VIIa inhibitors useful as anticoagulants
Infobox
Patent Number
0759233100
Patent Number
759233100
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 7 Apr, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075923310
Date of Patent
September 22, 2009
0Patent Application Number
116141310
Date Filed
December 21, 2006
0Official Website
Patent Primary Examiner
Edits on 26 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075923310
Date of Patent
September 22, 2009
0Patent Application Number
116141310
Date Filed
December 21, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 3 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07592331 Macrocyclic factor VIIa inhibitors useful as anticoagulants
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07592331
Date of patent
September 22, 2009
Patent application number
11614131
Date Filed
December 21, 2006
Patent primary examiner
Find more entities like US Patent 7592331 Macrocyclic factor VIIa inhibitors useful as anticoagulants
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
